[
  {
    "Company": "Cell Dynamics",
    "Model": "W8 Analysis of Cancer Spheroids",
    "Organs/Tissues": "Tumor spheroids (patient-derived or cell-line-derived)",
    "Physiological/Pathological": "Primarily pathological (cancer), can also do normal 3D cell aggregates",
    "Cell Source": "Any tumor cell line, primary cancer cells, co-culture with stromal fibroblasts",
    "Multiple Cell Types": "Yes (tumor + fibroblasts or immune cells in spheroid)",
    "Stromal Cells": "Yes (CAF in tumor spheroids)",
    "Tissue-resident Immune": "Possible if included in the spheroid",
    "Circulating Immune": "N/A (W8 is an analyzer, no circulation in device)",
    "Crosstalk (Multi-tissue)": "No multi-organ linking, single spheroid measurement",
    "Air-Liquid Interface": "No, spheroids in suspension media",
    "Extracellular Matrix": "Yes, if spheroids produce ECM or partial embedding",
    "3D Scaffold": "Yes, if grown in hydrogel prior to W8 measurement",
    "Notable Features": "Label-free measurement of spheroid mass, size, density. Sorting viable spheroids post-analysis.",
    "Plate/Format (Throughput)": "Low–medium throughput (tens of spheroids per run). Not a multi-well plate approach",
    "Max Culture Duration": "Spheroids are cultured externally; W8 is for short measurement",
    "Readouts - Live Imaging": "Basic imaging for size, not multi-channel fluorescence",
    "Readouts - Supernatant Sampling": "No (not in W8 itself)",
    "Readouts - Cell Retrieval": "Yes (spheroids can be recovered post measurement)",
    "Readouts - Whole Tissue": "Yes (the entire organoid can be removed for histology)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No (W8 uses physical measurement sensors)",
    "Dead Volume": "Minimal in microfluidics; short handling time",
    "Perfused": "No",
    "Gas Mix Controlled": "No, ambient conditions during measurement",
    "Real-time Microenvironment Control": "No, only end-point or repeated measurements",
    "model_availability": "Product only (instrument). No service indicated"
  },
  {
    "Company": "Cell Dynamics",
    "Model": "W8 Analysis of Patient-Derived Organoids (e.g., Glioblastoma, Prostate, etc.)",
    "Organs/Tissues": "Brain tumor organoids, prostate cancer organoids, or any patient-derived 3D tissue",
    "Physiological/Pathological": "Often pathological (tumor, disease organoids). Could measure healthy organoids too",
    "Cell Source": "Patient biopsy–derived organoids, co-culture with stroma",
    "Multiple Cell Types": "Yes (tumor cells + fibroblasts or other components)",
    "Stromal Cells": "Yes",
    "Tissue-resident Immune": "Possible if included in organoid",
    "Circulating Immune": "No perfusion in W8",
    "Crosstalk (Multi-tissue)": "No (single organoid measurement)",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes, organoids typically contain ECM",
    "3D Scaffold": "Yes (organoid self-assembly or scaffold-based)",
    "Notable Features": "Quantifies changes in organoid mass/density related to drug response, invasiveness",
    "Plate/Format (Throughput)": "Low–medium throughput, single organoid scanning at a time",
    "Max Culture Duration": "Organoids cultured externally; W8 usage is short",
    "Readouts - Live Imaging": "Basic brightfield for morphological measurement, not multi-channel",
    "Readouts - Supernatant Sampling": "Not in W8",
    "Readouts - Cell Retrieval": "Yes, organoids remain intact post measurement",
    "Readouts - Whole Tissue": "Yes, can do endpoint histology after W8",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low in the device’s microfluidic path",
    "Perfused": "No",
    "Gas Mix Controlled": "No active control",
    "Real-time Microenvironment Control": "No",
    "model_availability": "Instrument product"
  },
  {
    "Company": "Cell Dynamics",
    "Model": "W8 Analysis of 3D Spheroid Co-cultures (Non-cancer)",
    "Organs/Tissues": "Liver spheroids, cardiac microtissues, neural aggregates, etc.",
    "Physiological/Pathological": "Both – can measure healthy organoids or pathologic/fibrotic 3D structures",
    "Cell Source": "Any 3D culture (primary, iPSC-derived, etc.) in the 50–500 µm range",
    "Multiple Cell Types": "Yes (hepatocytes + stellate, cardiomyocytes + fibroblasts, etc.)",
    "Stromal Cells": "Yes",
    "Tissue-resident Immune": "If included in spheroid",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "No",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes, if produced by spheroid or used in scaffold",
    "3D Scaffold": "Yes, can measure scaffolded microtissues if free-floating",
    "Notable Features": "Label-free mass measurement, sorting spheroids for downstream assays",
    "Plate/Format (Throughput)": "Low–medium, manual loading of spheroids",
    "Max Culture Duration": "Not cultured in W8; short analysis time",
    "Readouts - Live Imaging": "Morphometric imaging only",
    "Readouts - Supernatant Sampling": "No (not in device)",
    "Readouts - Cell Retrieval": "Yes (spheroid fully recoverable)",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Minimal",
    "Perfused": "No",
    "Gas Mix Controlled": "No",
    "Real-time Microenvironment Control": "No",
    "model_availability": "Instrument product"
  }
]
